SVE
ENG

About Us
About Us
Close
Investors
Investors
Close
Media
Media
Close
Contact
Contact
Close

Search for:

About Us
Investors
Media
Contact

Search for:

November 17, 2017

CEO Interview Interim Report Q3 2017

Interview with InDex CEO Peter Zerhouni

Investors

The Share

Follow the share

InDex Pharmaceuticals Holding AB
Registration number: SE 559067-6820
Phone: +46 (0)8 122 038 50 | Berzelius väg 13, 171 65 Solna, Sweden

Contact us

Subscribe

Press releases

Financial reports

Read more about our protection of your personal data.

Cookies
Privacy Policy
Trademarks